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ABSTRACT. P53 protein is one of the main proteins in apoptosis pathway. The role of survivin protein in inhibition 
of P53 in different human cancers has been proved. The expression of survivin can be a main marker in diagnosis and 
prognosis of different human cancer. Until now, the survivin gene expression in birds infected with Marek’s disease 
was not investigated. In this study, liver tissue samples of chickens infected with Marek’s disease virus (MDV) was 
collected. The identification of MDV was carried out with PCR and histopathologic examination. After identification 
of MDV, the pathogenicity of infected virus was investigated with specific primers targeted on 132 bp tandem repeat. 
After this, the survivin gene expression was examined in neoplastic liver samples by Real-Time PCR. The PCR am-
plification of tumor liver samples showed that all samples were infected with MDV. The result of histopathology and 
amplification of 132 bp tandem repeat in tumor samples showed that the chickens were infected to pathogenic MDV. 
Results showed that the survivin gene expression in neoplastic hepatocytes was significantly higher than normal hepat-
ocytes. In conclusion, survivin gene expression can be utilized as a suitable biomarker in diagnosis of Marek’s disease 
in birds. It seems that viral meq oncogene in Marek’s disease can play role in induction of survivin expression in this 
disease that it is necessary to be proved.
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INTRODUCTION
Marek’s disease (MD) is a lymphoproliferative disease in chickens that caused by oncogenic 
herpesvirus (Tulman et al., 2000). This virus repli-
cates in the lymphoid and epithelial tissues (Biggs, 
2001). The virus can form lymphoma in different 
organs and caused anemia and immunosuppression 
in chickens, especially layers and breeders (Calnek, 
2001). The economic importance of this infection is 
related to mortality, decreased egg production and 
hatchability in chickens (Schat and Nair, 2013).  
The disease firstly described by Joseph Marek, a 
veterinarian, in a cockerel with nervous sign (Marek, 
1907). The virus can induce different and variety 
forms. The acute classic or visceral, neurological, 
cutaneous and ocular are common forms of this in-
fection. The prevalent and main form of MD is acute 
classical form that is characterized by lymphoma 
in different visceral organs like liver, heart, lungs, 
spleen, kidney, bursa of Fabricious, proventiculus and 
gonads (Calnek, 2001).
Survivin, a newly characterized member of the 
inhibitor of apoptosis proteins (IAP), is a bifunc-
tional protein which regulates cell proliferation and 
suppresses apoptosis (Altieri and Marchiso, 1999). 
Survivin is highly expressed during embryonic de-
velopment and fetal tissues (Altieri, 2015). There is 
limited information about survivin expression in most 
normal differentiated tissues (Ambrosini et al., 1997). 
Survivin is also overexpressed in a wide variety of 
human neoplasms, suggesting that reactivation of the 
survivin gene frequently occurs in neoplasms (Am-
brosini et al., 1997).
Currently, survivin protein expression is being 
used as a prognostic factor in several human neo-
plasms (Johson and Howerth, 2004). High survivin 
expression in human neoplasms associated with more 
aggressive behavior, reduced response to chemo-
therapeutic agents and decreased survival times, 
compared with neoplasms that are survivin negative 
(Altieri, 2015). Manipulation of survivin regulation 
and expression may leads to the development of new 
immunotherapy and gene therapy strategies for the 
treatment of neoplasms (Altieri and Marchiso, 1999). 
Until today, there is no information regarding survivin 
gene expression in chicken. 
The purpose of this study is to demonstrate the sur-
vivin gene expression in chicken’s neoplastic tissues 
and the comparison of the expression rate of survivin 
in normal and neoplastic tissues.
MATERIALS AND METHODS
After identification of chicken flock with MD, the 
suspected chickens were transferred to laboratory. 
The chickens euthanized and necropsied for sampling. 
The chickens that showed nodular lesions in viscer-
al organs were selected for further examination. For 
each flock, 3 liver samples with nodular lesions were 
taken. The sampling was carried out for the detection 
of MDV and identification of pathogenicity by PCR 
test, pathological examination and survivin expres-
sion by Real-Time PCR. The samples were collected 
from 5 suspected flocks. Furthermore, liver samples 
from 5 apparently healthy chickens were collected as 
negative control.
DNA was extracted from nodular and normal liver 
tissues using a commercial DNA extraction kit (Ac-
cuPrep Genomic DNA Extraction Kit, Bioneer co., 
South Korea).
PCR was carried out to amplify fragments of 314 
and 434 bp of the antigen A (specific for MDV-sero-
type 1) and 132 bp tandem repeat of MDV, respective-
ly. The sequences of the antigen A and 132 bp tandem 
repeat primers were as following: forward primer: 
5′-GAG GTA CCT CAT GGA CGT TCC ACA-3′; re-
verse primer: 5′-ACA TTC TTT TCG TTG GCG TGG 
TAT-3′ (Antigen A) (Bechker et al., 1992). Forward 
primer: 5′-TAC TTC CTA TAT ATA GAT TGA GAC 
GT-3′; reverse primer: 5′-GAG ATC CTC GTA AGG 
TGT AAT ATA-3′ (132 bp tandem repeat) (Bechker et 
al., 1992).  PCR amplification was performed in PCR 
buffer containing 2 mM MgCl2, 200 μM each dNTPs, 
1 μM each primer, and 1.0 unit of Taq polymerase 
(Fermentas, Germany) in a 25 μL total reaction vol-
ume. The 100 bp DNA ladder plus (Fermentas, St. 
Leon-Rot, Germany) was used. The amplification 
was carried out in a thermal cycler (Mastercycler 
Gradient, Eppendorf-Nethel-Hinz GmbH, Hamburg, 
Germany) using the following conditions: an initial 
denaturation at 95°C for 5 min, followed by 35 cycles 
of denaturation, annealing, and extension at 94°C for 
30 sec, 55°C for 30 sec, and 72°C for 60 sec respec-
tively, and a final extension at 72°C for 5 min. The 
PCR product was then analyzed by electrophoresis in 
1% agarose gel and visualized under UV light after 
staining with ethidium bromide. 
In this study live HVT vaccine (FC126 strain be-
longed to serotype 3, Merial, France) and sterile water 
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were utilized as positive and negative, respectively. 
For analysis of lymphocytic infiltration in liver, 
the tissue samples were fixed in neutral 10% forma-
line solution, embedded in paraffin and cut into 4 mi-
crometer thick sections. After deparaffinization, the 
sections were stained with hematoxylin-eosin (H & 
E) method (Bancrof and Stevens, 1996).
Total RNA was extracted from normal and neo-
plastic hepatocytes using a RNeasy kit (Qiagen, Va-
lencia, CA, USA) and cDNA was synthesized using a 
QantiTect Reverse Transcription Kit (Qiagen, Valen-
cia,CA, USA) according to manufacturer’s instruc-
tion.
Real-time RT-PCR for Survivin gene was per-
formed using specific QuantiTect primer assay (Fowl 
survivin, Cat no. QT00595896, Qiagen, Valencia, 
CA, USA) using the QuantiTect SYBR Green PCR 
kit (Qiagen, Valencia, CA, USA).
The GAPDH was used as housekeeping gene. For 
the amplification of the GAPDH gene a pair of prim-
ers was synthesized by Bioneer (South Korea). The 
primers’ sequences for chicken GAPDH were: For-
ward primer, 5’-GGTGGTGCTAAGCGTGTTA-3’; 
reverse primer, 5’-CCCTCCACAATGCCAA-3’, re-
sulting in an amplified product of 179 bp (Accession 
No. X01578) (Li et al., 2005).
Quantitative Real-Time RT-PCR was performed 
in a 20 μL reaction volume containing 10 μL of the 
SYBR Green PCR master mix (Fermentase, Germa-
ny), 1.5 μL of the RT reaction mixture, 0.5 μL each 
primers and 7.5 μL dH2O using the Applied Biosys-
tems StepOnePlusTM Real-time PCR system (Foster 
City, CA, USA). 
Amplification program included of initial denatur-
ation step at 95◦C for 10 minute, flowed by 40 amplifi-
cation cycles consisting of denaturation at 95◦C for 15 
s, annealing at 60◦C for 60 s, and extension at 72◦C for 
30 s. Real-Time PCR assays were carried out in tripli-
cates and repeated three times. Relative gene expres-
sion was calculated using the standard curve method.
All data were analyzed by the statistical package 
for social sciences (SPSS) version 18.0 software (Chi-
cago, Inc, USA) using one-way analysis of variance 
(ANOVA) statistical method at p< 0.05. 
RESULTS
In suspected chickens to MD, a variety of macro-
scopic lesions was observed in visceral organs where 
focal nodular and diffuse whitish spots on the liver 
were featured (Figure 1). In apparently healthy chick-
ens no macroscopic lesions were observed in liver or 
other organs.
Figure 1. The gross pathological lesions on liver in suspected 
chicken to MD.
The microscopic section of liver represents focal 
neoplastic infiltration which it is accompanied with 
pleomorphic cells. The neoplastic foci are consisting 
of lymphocyte and lymphoblast infiltration with dif-
ferent size, from small to medium (Figure 2). In ap-
parently healthy chickens with normal liver tissues no 
microscopic lesions were seen.
Figure 2. The neoplastic foci in liver of MDV infected chickens 
(H&E).
The 314 bp fragment related to antigen A of MDV 
was amplified in all liver samples with neoplastic le-
sions similar to positive control. In positive control, 
the 132 bp tandem repeat was not amplified while in 
all clinical samples the 132 bp tandem repeat with 
band size of 434 bp was amplified. The 314 and 434 
bp fragments were not amplified in samples from ap-
parently healthy chickens (Figure 3).
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Figure 3. The PCR amplification of the Antigen A and 132bp 
tandem repeat of MDV in tissue samples from chickens (Lane 
1: DNA ladder marker (100 bp) ; lanes 2: positive samples for 
Antigen A of MDV; Lane 3: positive samples for 132 bp tandem 
repeat; Lane 4: positive control (HVT Vaccine); and Lane 5: neg-
ative control).
The results showed that survivin is expressed in 
normal and neoplastic hepatocytes in chickens. The 
expression rate of survivin in normal and neoplastic 
hepatocytes was 0.113±0.136 and 1.440±0.500, re-
spectively. The comparison of expression rate showed 
that there is a significant difference in survivin gene 
expression in normal and neoplastic hepatocytes in 
apparently healthy and MDV infected chickens (Fig-
ure 4). 
Figure 4. The expression of survivin gene in normal and neoplas-
tic hepatocytes in chicken.
DISCUSSION
Marek’s disease is the most important infectious 
disease in layers and characterized by development of 
lymphomas in different visceral, epithelial and nerv-
ous organs (Schat and Nair, 2013). PCR is the rapid 
and sensitive test to detect the presence of MDV in 
clinical samples (Shahzad, et al., 2007). Becker et al 
(1992) had designed one pair of primers that it could 
distinguished the pathogenic and non pathogenic 
MDV by a  PCR assay amplified a 343 bp fragment 
of 132 bp tandem repeat. Zhu et al (1992), Becker 
et al (1992) and Kozdrun et al (2001) have declared 
that the PCR tests can be used for the identification 
of virulent MDV DNA in pathological samples and 
to distinguish between the virulent and non-virulent 
MDV in chickens. Therefore, in this study were uti-
lized two pairs of primers designed on secretory an-
tigen A and on the tandem repeat of 132 bp in order 
to identify MDV DNA in clinical samples and to dif-
ferentiate the detected DNA, respectively. PCR and 
pathology results estimated that the sampling stage 
has been in stage of tumorigenesis of virus which in 
this time point, the viral antigen has been detected in 
tissues with microscopic lesions. Although this study 
increased knowledge regarding the Marek’s disease 
of birds, it can be also used as a model about human 
cancer.
P53 protein is one of the most fundamental pro-
teins for apoptosis induction and tumor inhibition 
(Shaikh and Niranjan, 2015). In normal condition, 
activation of apoptosis pathway and cell proliferation 
preserves normal size and performance of tissues (Na-
chmias et al., 2004). Mutation in protein P53 could 
lead to inactivation of apoptosis pathway, disorder of 
cell biochemical reactions and abnormal growth of 
cells (Shaikh and Niranjan, 2015). Survivin has been 
identified as a member of IAPs family (Johnson and 
Howerth, 2004). In this study, survivin gene expres-
sion in MDV infected hepatocytes in chickens was 
investigated and evaluated by sensitive and precise 
method of Real-Time PCR. Survivin plays role in cell 
proliferation, decrease of apoptosis of tumor cells, 
resistance to chemotherapy, radiotherapy and recur-
rence of many human cancers (Alteiri, 2015; Johnson 
and Howerth, 2004; Lei et al., 2010). But until today, 
it hasn’t been investigated in tumor cells of birds. This 
gene is available in most germinal cells or in differen-
tial cells and most of cancers (Altieri, 2015). High ex-
pression of survivin in cancer cells indicates its prom-
inent role for apoptosis inhibition during development 
of tumor. The gene is considerably expressed almost 
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in all human tumors (Verdecia et al., 2000). The can-
cers that have been reported high expression of this 
gene include lung, breast, gastric, esophagous, thy-
roid, colon (Altieri, 2015), larynx, pancreatic (Kato 
et al., 2001), bladder (SWANA et al., 1999), uterine 
(Saitoh et al., 1999), ovarian (Yoshida et al., 2001), 
liver (Ito et al., 2000), non-melanoma skin (Grossman 
et al., 1999) cancers. Tamm et al (2000) investigated 
expression of survivin in 60 lines of human cancer 
cells and observed high expression of survivin for all 
60 samples. Furthermore, it has been recently indicat-
ed that anti-survivin drugs sensitizes tumor to chemo-
therapy by induction of apoptosis (Olie et al., 2000).
Thus, survivin is studied as a suitable antigen for both 
diagnosis and treatment.
In current study, survivin gene was expressed and 
compared in liver normal and tumor cells but its ex-
pression rate was significantly higher in tumor cells. 
It seems the high expression of survivin in liver tumor 
cells in MDV infected chickens could be attributed 
to the interaction of meq oncogenes of Marek’s virus 
with P53 protein. Recently, correlation between meq 
protein of  MDV and HSP70 has been proved as an in-
ductor of neoplasm (Zhao et al., 2009) and CDK2 and 
Rb proteins have been proved as regulators of cell cy-
cle (Altieri, 2015; Shaikh and Niranjan, 2015, Nach-
mais et al., 2004; Zhao et al., 2009). Also, it has been 
shown that meq protein could shorten G1 phase of 
cell cycle (Nair and Kung, 2004). In this regard, some 
studies indicate that viruses’ oncogenes are effective 
in high expression of survivin. So, already relation-
ship between protein X of hepatitis B virus in human 
hepatocarcinoma (Marusawa et al., 2003), protein 
Tax type 1 of T-cell leukemia virus (Kawakami et al., 
2005) and protein E6 of popilloma virus (type 16) in 
uterine cancer (Borbely et al., 2006) with the overex-
pression of survivin gene has been indicated. Also, it 
has been shown that oncogene protein LMP2A of Ep-
stein-bar virus can induce the expression of survivin 
and the prohibition of apoptosis (Hino et al., 2008). 
Therefore, the high survivin expression in liver tumor 
cells could be due to the activation by meq oncogene 
of MDV.
In this study, has been shown that survivin expres-
sion in liver tumor cells has significantly been higher 
than liver normal cells. Survivin expression in normal 
cells can be explained by the presence of very small 
numbers of stem cells (Altieri 2005) in liver tissue 
that could be used for the preservation of tissue ho-
meostasis. Liver tissue is always regenerating cells 
to preserve the tissue homeostasis against different 
chemical materials including drugs and bacterial tox-
ins. Expression of survivin gene in this organ could 
be associated with the existence of premature and un-
differentiated cells at primary step of cell regenera-
tion. In addition, an inhibitor of apoptotic proteins has 
been observed in some cells of soft tissues.  Chen et 
al (2003) and Berendse et al (2003) showed reduced 
gene expression of GLN3 in normal muscle tissue 
that is because of presence of some myoblast cells 
with properties of stem cells in muscle tissues. Fan 
et al (2006) presented gene expression of GLN3 in 
normal tissue and renal tumors that this finding may 
be as a result of increased proliferation of renal epi-
thelial cells. Thus, according to the low expression of 
survivin gene in normal liver cell, the high expression 
of the gene in tumor hepatocytes could be used as a 
target for immunotherapy in MDV infected birds
In conclusion, the results of this study showed that 
survivin gene is significantly expressed as an inhibi-
tor of apoptosis gene in tumors with MDV origin in 
chickens. Immunotherapy of this protein creates a 
new perspective for the treatment of Marek’s disease 
in valuable birds.
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